• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Depressive Disorder, Treatment-Resistant

Depressive Disorder, Treatment-Resistant - 26 Studies Found

Completed : Interpersonal Psychotherapy for Treatment Resistant Depression
: Treatment Resistant Depression
: 2013-07-01
:
  • Other: IPT+ antidepressant drugs

Completed : Structural and Functional Connectivity of Brainstem Monoamine Pathways in Treatment Resistant Depression
: Treatment Resistant Depression
: 2017-03-01
: Drug: Monoamine Oxidase Inhibitor (MAOI) Monoamine Oxidase Inhibitor
Terminated : Aripiprazole Augmentation Therapy in Treatment-resistant Depression
: Therapy-resistant Depression
: 2006-01-11
: Drug: Aripiprazole Addition of Aripiprazole 10 mg to concurrent medication
Completed : Exercise in Treatment Resistant Depression (TRD): A Feasibility Study
: Treatment Resistant Depression
: 2011-06-23
:
  • Other: Moderate Intensity Aerobic Exercise

Terminated : Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled Trial
: Therapy-resistant Depression
: 2006-01-04
:
  • Drug: Olanzapine 10 mg Olanzap

Active, not recruiting : Trial of Low Field Magnetic Stimulation Augmentation of Antidepressant Therapy in Treatment-Resistant Depression
: Treatment Resistant Depression
: 2012-07-30
:
  • Device: Low Field Magnetic Stimulation (LFMS)

Completed : A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
: Treatment-resistant Depression
: 2015-05-18
:
  • Drug: Esketamine (Intranasal Spray)

Completed : A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
: Treatment-resistant Depression
: 2015-04-10
:
  • Drug: Esketamine Participants

Completed : A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
: Treatment-resistant Depression
: 2015-04-13
:
  • Drug: Esketamine Participants

Terminated : Proof-of-Concept Trial of CERC-501 Augmentation of Antidepressant Therapy in Treatment-Resistant Depression
: Treatment Resistant Depression
: 2013-07-30
:
  • Drug: CERC-501 Dose of CERC-50

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.